Publications by authors named "Forough Nourani"

2 Publications

  • Page 1 of 1

Benefit of urinalysis.

Indian J Pediatr 2009 Jun 23;76(6):639-41. Epub 2009 Apr 23.

Department of Pediatric Nephrology, Shahid Sadoughi Hospital, School of Medicine, Yazd, Iran.

Objective: In the pilot Iran school screening programme, the minimal cost of screening dipstick urinalysis in 1601 asymptomatic school children was determined.

Methods: The cost of screening dipstick urinalysis was calculated by reviewing the literature for the prevalence of asymptomatic proteinuria, hematuria, bacteriuria, and glucosuria determined by an initial dipstick urinalysis. The minimal cost utilizing data of 3 general physicians was calculated. Costs were determined by using current charge for supplies ordered to perform tests, charges for tests performed by a commercial laboratory, and the cost of a final evaluation by a pediatric nephrologist.

Results: 4.7% (76/1601) of patients were calculated to have an initial abnormal urinalysis. Upon retesting 1.37% (22/1601) of patients were calculated to have a persistent abnormality. The calculated cost was $167 to initially screen all 1601 patients with a dipstick urinalysis or $0.092 per patient. The calculated cost to evaluates the 22 patients with any persistent abnormality on repeat dipstick urinalysis was $0.02 or $0.001 per patient. This is the calculated cost for a single screening of 1601 asymptomatic pediatric patients.

Conclusion: Multiple screening dipstick urinalysis in asymptomatic pediatric is costly and should be discontinued. We propose that a single screening dipstick urinalysis be obtained at school entry age, between 6 and 7 years, in all asymptomatic children.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
June 2009

Effect of sodium metavanadate supplementation on lipid and glucose metabolism biomarkers in type 2 diabetic patients.

Malays J Nutr 2008 Mar 15;14(1):113-9. Epub 2008 Mar 15.

Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Type 2 diabetes mellitus is a chronic, progressive illness that causes considerable morbidity and premature mortality. Vanadium is a trace mineral that has been claimed to be effective in controlling blood glucose levels in diabetic patients. A randomised placebo-controlled study was conducted to evaluate the effect of sodium metavanadate on selected biochemical markers in type 2 diabetic patients. Forty patients were enrolled and half of them received 100 mg sodium metavanadate daily for 6 weeks while the other half were placebo subjects. The mean age of the patients was 53.1 ± 8.5 years. Body mass index (BMI), blood pressure(BP), fasting blood sugar (FBS), 2-h postprandial glucose, glycated hemoglobin (HbA1C), triglyceride(TG), total cholesterol (TC), low-density lipoproteins (LDL), high-density lipoproteins (HDL) were determined before the start and at the end of the study. Levels of FBS, HbA1C, TC and LDL in the diabetic subjects decreased after six weeks on sodium metavanadate, but the differences were not statistically significant on comparing between pre- and posttrial levels. Based on the results, this study did not find sodium metavanadate of beneficial use as a form of vanadium supplementation among patients with type 2 diabetes.
View Article and Find Full Text PDF

Download full-text PDF

March 2008